CO2019005761A2 - Composiciones y métodos para la producción incrementada de enduracidina en una cepa genéticamente modificada de streptomyces fungicidicus - Google Patents

Composiciones y métodos para la producción incrementada de enduracidina en una cepa genéticamente modificada de streptomyces fungicidicus

Info

Publication number
CO2019005761A2
CO2019005761A2 CONC2019/0005761A CO2019005761A CO2019005761A2 CO 2019005761 A2 CO2019005761 A2 CO 2019005761A2 CO 2019005761 A CO2019005761 A CO 2019005761A CO 2019005761 A2 CO2019005761 A2 CO 2019005761A2
Authority
CO
Colombia
Prior art keywords
methods
genetically modified
compositions
streptomyces fungicidicus
enduracidine
Prior art date
Application number
CONC2019/0005761A
Other languages
English (en)
Inventor
Mark T Zabriskie
Xihou Yin
Original Assignee
Univ Oregon State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Oregon State filed Critical Univ Oregon State
Publication of CO2019005761A2 publication Critical patent/CO2019005761A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/71—Expression systems using regulatory sequences derived from the trp-operon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/76—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Esta descripción describe composiciones y métodos para mejorar la producción de enduracidina en cepas genéticamente modificadas de Streptomyces fungicidicus. En particular, la presente descripción describe la manipulación genética de los genes reguladores orf24 y orf18 asociados con la agrupación de genes de biosíntesis de enduracidina (enramicina) de Streptomyces fungicidicus para generar constructos de vectores y cepas recombinantes que producen mayores rendimientos de enduracidina.
CONC2019/0005761A 2016-12-06 2019-05-31 Composiciones y métodos para la producción incrementada de enduracidina en una cepa genéticamente modificada de streptomyces fungicidicus CO2019005761A2 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662430838P 2016-12-06 2016-12-06
US201762479087P 2017-03-30 2017-03-30
PCT/US2017/064328 WO2018106545A1 (en) 2016-12-06 2017-12-01 Compositions and methods for enhanced production of enduracidin in a genetically engineered strain of streptomyces fungicidicus

Publications (1)

Publication Number Publication Date
CO2019005761A2 true CO2019005761A2 (es) 2019-08-30

Family

ID=60788701

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2019/0005761A CO2019005761A2 (es) 2016-12-06 2019-05-31 Composiciones y métodos para la producción incrementada de enduracidina en una cepa genéticamente modificada de streptomyces fungicidicus

Country Status (12)

Country Link
US (2) US11447530B2 (es)
JP (1) JP7086984B2 (es)
CN (1) CN110997700A (es)
BR (1) BR112019011378A2 (es)
CO (1) CO2019005761A2 (es)
MX (2) MX2019006522A (es)
MY (1) MY200048A (es)
PE (1) PE20191767A1 (es)
PH (1) PH12019501228A1 (es)
TW (2) TWI828613B (es)
UA (1) UA127452C2 (es)
WO (1) WO2018106545A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113980881B (zh) * 2021-11-11 2023-09-19 枣庄市杰诺生物酶有限公司 一种高产恩拉霉素的杀真菌素链霉菌工程菌
CN115261258A (zh) * 2022-06-07 2022-11-01 四川汇邦环保科技有限公司 一种降解持久霉素的微生物菌剂

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617881C2 (de) 1965-10-13 1984-07-05 Takeda Chemical Industries, Ltd., Osaka Antibiotikum Enduracidin und seine Herstellung
JPS6038120B2 (ja) 1980-10-31 1985-08-30 武田薬品工業株式会社 抗生物質エンジユラサイジンの製造法
CA1323293C (en) 1987-12-11 1993-10-19 Keith C. Backman Assay using template-dependent nucleic acid probe reorganization
EP0425563B1 (en) 1988-07-20 1996-05-15 David Segev Process for amplifying and detecting nucleic acid sequences
US5427930A (en) 1990-01-26 1995-06-27 Abbott Laboratories Amplification of target nucleic acids using gap filling ligase chain reaction
US5648211A (en) 1994-04-18 1997-07-15 Becton, Dickinson And Company Strand displacement amplification using thermophilic enzymes
KR100392551B1 (ko) 1994-07-15 2003-10-30 아크조 노벨 엔브이 핵산 증폭방법을 개선시키기 위한 rna폴리머라제의 용도
AT402203B (de) 1995-06-13 1997-03-25 Himmler Gottfried Dipl Ing Dr Verfahren zur transkriptionsfreien amplifizierung von nucleinsäuren
CA2255774C (en) 1996-05-29 2008-03-18 Cornell Research Foundation, Inc. Detection of nucleic acid sequence differences using coupled ligase detection and polymerase chain reactions
US8188245B2 (en) 2006-09-29 2012-05-29 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Enduracidin biosynthetic gene cluster from streptomyces fungicidicus
CN103374537B (zh) 2012-04-25 2015-01-07 牡丹江佰佳信生物科技有限公司 一种制备恩拉霉素的方法及其生产菌株
CN104131054B (zh) 2014-06-17 2017-02-01 安徽丰原发酵技术工程研究有限公司 一种用于提高恩拉霉素产量的发酵培养基及发酵方法
CN104561048A (zh) 2015-01-23 2015-04-29 天津科技大学 杀真菌素链霉菌恩拉霉素抗性好且产量高的基因和菌株
MX2019006586A (es) 2016-12-06 2019-08-22 Intervet Int Bv Aislamientos de streptomyces fungicidicus modificados y su uso.

Also Published As

Publication number Publication date
PH12019501228A1 (en) 2019-10-07
RU2019120981A (ru) 2021-01-12
JP7086984B2 (ja) 2022-06-20
TWI828613B (zh) 2024-01-11
MY200048A (en) 2023-12-06
US20230120672A1 (en) 2023-04-20
CN110997700A (zh) 2020-04-10
PE20191767A1 (es) 2019-12-17
US20190359659A1 (en) 2019-11-28
MX2019006522A (es) 2020-02-20
RU2019120981A3 (es) 2021-08-23
BR112019011378A2 (pt) 2019-10-15
UA127452C2 (uk) 2023-08-30
US11858967B2 (en) 2024-01-02
TW201827591A (zh) 2018-08-01
TW202417610A (zh) 2024-05-01
JP2020500561A (ja) 2020-01-16
WO2018106545A1 (en) 2018-06-14
US11447530B2 (en) 2022-09-20
MX2023003316A (es) 2023-03-27

Similar Documents

Publication Publication Date Title
AR113881A1 (es) Composiciones y métodos para el tratamiento de desórdenes inmunes usando la cepa blautia
CL2018003142A1 (es) Moduladores de la vía de estrés integrada
CL2022001372A1 (es) Construcciones para terapia génica con microdistrofina y uso de las mismas.
MX2018001776A (es) Celulas para inmunoterapia modificadas geneticamente para dirigirse al antigeno cd38 y para la inactivacion del gen cd38.
CO2017001573A2 (es) Receptor quimérico de antígeno anti-cd123
MX2016010345A (es) Celulas para inmunoterapia diseñadas para dirigir antigeno presente tanto en celulas inmunes y celulas patologicas.
MX2022006513A (es) Constructos de expresion y metodos para dise?ar geneticamente levadura metilotrofica.
CO2017000506A2 (es) Receptor quimérico de antígeno cll-1
BR112017001470A2 (pt) métodos e composições para atenuar as respostas imunes do vetor de transferência anti-viral de terapia genética
PE20190563A1 (es) Genes de mini-distrofina optimizados y casetes de expresion y su uso
CO2018005876A2 (es) Inmunoglobulinas conjugadas con lisina c-terminal
AR113490A1 (es) CONSTRUCCIONES DE ARNi PARA INHIBIR LA EXPRESIÓN DE PNPLA3 Y MÉTODOS DE USO DE LAS MISMAS
MX2021000638A (es) Métodos y composiciones de construcciones y vectores de acidemia metilmalónica.
MX2019006722A (es) Construcciones de adenovirus de chimpance con antigenos de lyssavirus.
ES2572215T3 (es) Anticuerpo neutralizante contra el receptor de prolactina Mat3 y su uso terapéutico
CR20180228A (es) Terapia adjunta con 25-hidroxi vitamina d y articulos de la misma
PE20211225A1 (es) Constructos de arni para inhibir la expresion de pnpla3
TWD179688S (zh) 人形玩具之部分
MX2020013269A (es) Inhibidores de la vía de respuesta al estrés integrada.
CO2019005761A2 (es) Composiciones y métodos para la producción incrementada de enduracidina en una cepa genéticamente modificada de streptomyces fungicidicus
EP3998341A3 (en) Adenoviral vectors
BR112018006026A2 (pt) liberação de gene aperfeiçoada para células assassinas naturais, células troncos hematopoiéticas e macrófagos
EA201891335A1 (ru) Добавление аргинина с целью повышения эффективности ацетогенов, ферментирующих газ
MX2020004063A (es) Sistemas y metodos para producir celulas b modificadas geneticamente para expresar anticuerpos seleccionados.
PH12021550306A1 (en) Self-selecting sterile male arthropods